3'-deoxysangivamycin

Also Known As:

4-amino-7-(3-deoxy-beta-D-ribofuranosyl)pyrrolo(2,3-d)pyrimidine-5-carboxamide; 7H-Pyrrolo(2,3-d)pyrimidine-5-carboxamide, 4-amino-7-(3-deoxy-beta-D-erythro-pentofuranosyl)-

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Pyrimidines: 510
    - Pyrimidine Nucleosides: 50
      - 3'-deoxysangivamycin: 1
Nucleic Acids, Nucleotides, and Nucleosides: 1
- Nucleosides: 6847
  - Pyrimidine Nucleosides: 50
    - 3'-deoxysangivamycin: 1

Related Diseases

1.	Leukemia L1210 01/01/1983 - "Antitumor evaluation showed that 3'-deoxysangivamycin had significant activity against the murine leukemia L1210 both in vivo and in vitro, although it was less potent on a molar basis than the parent compound sangivamycin. "

Related Drugs and Biologics

1.	sangivamycin